Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
Harvard Bioscience (NASDAQ: HBIO) has announced it will release its financial results for Q1 2025 (quarter ended March 31, 2025) before market opens on May 12, 2025. The company will host a conference call at 8:00 AM Eastern Time to discuss the results. Interested participants who wish to ask questions must pre-register to receive dial-in numbers and a unique PIN. An audio-only webcast option is also available through the company's investor website. The earnings release and related presentation materials will be accessible through Harvard Bioscience's Investor Relations section.
Harvard Bioscience (NASDAQ: HBIO) ha annunciato che pubblicherà i risultati finanziari del primo trimestre 2025 (trimestre terminato il 31 marzo 2025) prima dell'apertura dei mercati il 12 maggio 2025. La società terrà una conference call alle 8:00 AM ora Eastern per discutere i risultati. I partecipanti interessati che desiderano porre domande devono registrarsi in anticipo per ricevere i numeri di accesso e un PIN univoco. È disponibile anche un webcast solo audio tramite il sito web per gli investitori della società. Il comunicato sugli utili e i materiali di presentazione correlati saranno accessibili nella sezione Investor Relations di Harvard Bioscience.
Harvard Bioscience (NASDAQ: HBIO) ha anunciado que publicará sus resultados financieros del primer trimestre de 2025 (trimestre finalizado el 31 de marzo de 2025) antes de la apertura del mercado el 12 de mayo de 2025. La compañía realizará una conferencia telefónica a las 8:00 AM hora del Este para discutir los resultados. Los participantes interesados que deseen hacer preguntas deben preinscribirse para recibir los números de acceso y un PIN único. También está disponible una opción de webcast solo de audio a través del sitio web para inversores de la compañía. El comunicado de ganancias y los materiales de presentación relacionados estarán accesibles en la sección de Relaciones con Inversores de Harvard Bioscience.
Harvard Bioscience (NASDAQ: HBIO)는 2025년 1분기 실적(2025년 3월 31일 종료 분기)을 2025년 5월 12일 시장 개장 전 발표할 예정입니다. 회사는 동부 표준시 오전 8시에 실적을 논의하기 위한 컨퍼런스 콜을 개최합니다. 질문을 희망하는 참가자는 사전에 등록하여 전화 접속 번호와 고유 PIN을 받아야 합니다. 회사 투자자 웹사이트를 통해 오디오 전용 웹캐스트 옵션도 제공됩니다. 실적 발표 및 관련 자료는 Harvard Bioscience의 투자자 관계 섹션에서 확인할 수 있습니다.
Harvard Bioscience (NASDAQ: HBIO) a annoncé qu'elle publiera ses résultats financiers du premier trimestre 2025 (trimestre clos le 31 mars 2025) avant l'ouverture des marchés le 12 mai 2025. La société tiendra une conférence téléphonique à 8h00, heure de l'Est pour discuter des résultats. Les participants intéressés souhaitant poser des questions doivent s'inscrire à l'avance pour recevoir les numéros d'appel et un code PIN unique. Une option de webdiffusion audio uniquement est également disponible via le site web des investisseurs de la société. Le communiqué de résultats ainsi que les documents de présentation associés seront accessibles dans la section Relations Investisseurs de Harvard Bioscience.
Harvard Bioscience (NASDAQ: HBIO) hat angekündigt, dass die Finanzergebnisse für das erste Quartal 2025 (Quartal bis zum 31. März 2025) vor Markteröffnung am 12. Mai 2025 veröffentlicht werden. Das Unternehmen wird um 8:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Interessierte Teilnehmer, die Fragen stellen möchten, müssen sich vorab registrieren, um Einwahlnummern und eine eindeutige PIN zu erhalten. Eine reine Audio-Webcast-Option ist ebenfalls über die Investor-Website des Unternehmens verfügbar. Die Gewinnmitteilung und die zugehörigen Präsentationsmaterialien sind im Bereich Investor Relations von Harvard Bioscience zugänglich.
- None.
- None.
HOLLISTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2025, before the market opens on May 12, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Company Contact:
Jennifer Cote
Chief Financial Officer
(508) 893-3120
investors@harvardbioscience.com
FAQ
When will Harvard Bioscience (HBIO) report Q1 2025 earnings?
What time is Harvard Bioscience's Q1 2025 earnings conference call?
How can I participate in Harvard Bioscience's Q1 2025 earnings call?
Where can I find Harvard Bioscience's Q1 2025 earnings materials?
